Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Canadian drug developer Theratechnologies becomes takeover target https://t.co/zJJ18zopF6
Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company $THTX https://t.co/RR3N3hyQa3
Future Pak has made two cash-and-CVR offers to buy all $THTX shares, most recently proposing $3.51 to $4.50 per share. The deal values Theratechnologies at up to $255M See More Biotech Updates👇 https://t.co/tr7VEA9cs4 $PTN $CDT $VERO $ARGX $RXRX $SHPH $ZLAB $ONCY $SCLX https://t.co/QLkSpH6aYH
Future Pak has submitted proposals to acquire Theratechnologies Inc. (ticker: $THTX), offering a total value of up to $255 million. The company has made two cash-and-contingent value right (CVR) offers, proposing a price range of $3.51 to $4.50 per share for all outstanding shares of Theratechnologies. In response, Theratechnologies announced that it is engaged in exclusive discussions with another potential acquiror regarding the sale of the company. This development positions Theratechnologies as a notable target in the Canadian pharmaceutical sector.
